0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Research Letter | 
Kevin R. Riggs, MD, MPH; Jodi B. Segal, MD, MPH; Eun Ji Shin, MD, PhD; et al.
JAMA. 2016;315(5):514-515. doi:10.1001/jama.2015.15278.

Original Investigation | 
Alexi A. Wright, MD, MPH; Nancy L. Keating, MD, MPH; John Z. Ayanian, MD, MPP; et al.
JAMA. 2016;315(3):284-292. doi:10.1001/jama.2015.18604.
Includes: CME, Supplemental Content

Research Letter | 
Christine M. Veenstra, MD, MSHP; Scott E. Regenbogen, MD, MPH; Sarah T. Hawley, PhD, MPH; et al.
JAMA. 2015;314(24):2688-2690. doi:10.1001/jama.2015.12383.

JAMA Patient Page |  FREE
Ali A. Mokdad, MD, MS; Amit G. Singal, MD, MS; Adam C. Yopp, MD
JAMA. 2015;314(24):2701. doi:10.1001/jama.2015.15425.
Includes: Supplemental Content

Global Health | 
M. J. Friedrich
JAMA. 2015;314(23):2496. doi:10.1001/jama.2015.16382.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(21):2227. doi:10.1001/jama.2015.16166.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(17):1789. doi:10.1001/jama.2015.14009.

Editorial | 
J. Michael McGinnis, MD, MPP
JAMA. 2015;314(16):1699-1700. doi:10.1001/jama.2015.12391.

Editorial | 
Scott A. Strong, MD; Nathaniel J. Soper, MD
JAMA. 2015;314(13):1343-1345. doi:10.1001/jama.2015.11454.

Original Investigation | 
James Fleshman, MD; Megan Branda, MS; Daniel J. Sargent, PhD; et al.
JAMA. 2015;314(13):1346-1355. doi:10.1001/jama.2015.10529.
Includes: CME, Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Editorial  | 
AREG and EREG as Predictive Biomarkers for RAS Wild-Type Colorectal Cancer Treated With Panitumumab A Fresh Approach to an Old Puzzle
Elizabeth C. Smyth, MB, BCh, MSc; Khurum Khan, MBBS; David Cunningham, FMedSci
JAMA Oncology
Original Investigation  | 
Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer
Jenny F. Seligmann, PhD; Faye Elliott, MSc; Susan D. Richman, PhD; et al.
JAMA Oncology
Invited Commentary  | 
Biomarkers of Fluorouracil Toxicity Insight From the PETACC-8 Trial
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncology
Original Investigation  | 
DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer A Secondary Analysis of the PETACC-8 Randomized Clinical Trial
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.